1. CLRM-08 TARGETING IMMUNE-PAYLOAD TO THE GLIOBLASTOMA TUMOR MICROENVIRONMENT USING A MACROPHAGE-BASED TREATMENT RELYING ON AUTOLOGOUS, GENETICALLY MODIFIED, HEMATOPOIETIC STEM CELL-BASED THERAPY: THE TEM-GBM STUDY (NCT03866109). (5th August 2022) Authors: Eoli, Marica; Farina, Francesca; Gentner, Bernhard; Capotondo, Alessia; Anghileri, Elena; Barcella, Matteo; Brambilla, Valentina; Bruzzone, Maria Grazia; Carrabba, Matteo; Cuccarini, Valeria; d'Alessandris, Giorgio; Meco, Francesco Di; Ferla, Valeria; Franzin, Alberto; Ferroli, Paolo; Gagliardi, ... Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTIM-19. TEM-GBM: A PHASE I-IIA DOSE-ESCALATION STUDY DELIVERING IFN-Α WITHIN GLIOBLASTOMA MULTIFORME TUMOR MICROENVIRONMENT BY GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES. (12th November 2021) Authors: Finocchiaro, Gaetano; Gentner, Bernhard; Marica, Eoli; Francesca, Farina; Capotondo, Alessia; Ferla, Valeria; Carrabba, Matteo; Cuccarini, Valeria; Meco, Francesco Di; Legnani, Federico; Pollo, Bianca; Saini, Marco; Ferroli, Paolo; Pallini, Roberto; D'Alessandris, Giorgio; Patanè, Monica; Paterra... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMMU-01. TEM-GBM: AN OPEN-LABEL, PHASE I/IIA DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND EFFICACY OF GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES TO DELIVER IFN-A WITHIN GLIOBLASTOMA TUMOR MICROENVIRONMENT. (21st September 2021) Authors: Finocchiaro, Gaetano; Eoli, Marica; Gentner, Bernhard; Capotondo, Alessia; Anghileri, Elena; Antonarelli, Gabriele; Barcella, Matteo; Bruzzone, Maria Grazia; Carrabba, Matteo; Cuccarini, Valeria; D'Alessandris, Quintino G; DiMeco, Francesco; Farina, Francesca; Ferla, Valeria; Ferroli, Paolo; Gagl... Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Temferon an ex-vivo genetically modified cell therapy aiming to fill the gaps for solid tumor immunotherapy. Issue 9 (2020) Authors: Mazzoleni, Stefania; Gentner, Bernhard; Brambilla, Valentina; Magnani, Tiziana; Ciceri, Fabio; Finocchiaro, Gaetano; , Luigi Naldini; Russo, Carlo Journal: Cell & gene therapy insights Issue: Volume 6:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗